this mean in patients required the maximum dose (450 mg) we should inject in 3 different sites (which may be not convenient to the patient)
Recently a center in Beirut administered xolair at 225 mg per inj site ( the 450 mg administered in 2 inj sites) and the outcome was good but I did not a published study in this regard